Abstract:The chemical stability behavior of liraglutide was studied by exposing the drug substance to oxidative and hydrolytic stress conditions. A simple liquid chromatography method detected 19 degradation products under acidic, basic and oxidative stress conditions, which were identified and characterized. Liraglutide (LGT) is a synthetic glucagon‐like peptide‐1 analogue mainly used for the treatment of type‐2 diabetes or obesity. Comprehensive stability testing is essential in the development and routine quality control of synthetic therapeutic peptide pharmaceuticals. The GLP‐1 peptide drugs are usually formulated in aqueous‐base solution, which can generate stability issues during manufacturing, storage or shipment. The current study endeavors to observe the chemical stability behavior of LGT by exposing the drug substance to oxidative and hydrolytic stress conditions. A simple liquid chromatography (LC) method was developed where sufficient resolution between LGT and the generated degradation products was achieved. In total, 19 degradation products (DPs) were separated under acidic, basic and oxidative stress conditions. Using LC‐HRMS, MS/MS studies, the generated degradation products were identified and characterized. The mechanistic fragmentation pathway for all generated DPs were established and the plausible chemical structure for the identified DPs was predicted based on MS/MS data. The results strongly suggest that LGT is highly susceptible to degrade under oxidative and hydrolytic conditions. Furthermore, this study provides insights into the hydrolytic and oxidative stability of LGT, which can be implied during generic and novel formulation drug development and discovery in synthesizing relatively stable GLP‐1 analogues.

Method for solid phase synthesis liraglutide

Efficient Synthesis of Liraglutide by Using Oxyma As Coupling Reagent

Synthesis and Characterization of (R)-Minipeg-containing Chiral Γ-Peptide Nucleic Acids Using the Fmoc Strategy

A two-step method preparation of semaglutide through solid-phase synthesis and inclusion body expression

Solid-phase Synthesis of Bivalirudin and Its Method Optimization

One-step purification and immobilization of his-tagged GL-7-ACA acylase

Convenient Access to Glutamic Acid Side Chain Homologues Compatible with Solid Phase Peptide Synthesis.

A new approach for the synthesis of O-glycopeptides through a combination of solid-phase glycosylation and fluorous tagging chemistry (SHGPFT).

Development of A Large Scale Asymmetric Synthesis of the Glucocorticoid Agonist Bi 653048 Bs H3po4

Solid Phase Peptide Synthesis using side-chain unprotected arginine and histidine, with Oxyma Pure/TBEC in green solvents.

A comprehensive study on the identification and characterization of major degradation products of synthetic liraglutide using liquid chromatography‐high resolution mass spectrometry

Size-exclusion LC-UV/HRMS based method for the analysis of aggregates in synthetic GLP-1 analog liraglutide and evaluation of excipient impact on aggregation

Synthesis of a Potential Precursor (Northern Fragment) for the Cyclic Depsipeptides Vioprolides A and C

Improved Tag-Assisted Liquid-Phase Peptide Synthesis: Application to the Synthesis of the Bradykinin Receptor Antagonist Icatibant Acetate

Preparation Of D-Glutamine From Glutamic Acid

Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis

Fatty aldehyde bisulfite adducts as a purification handle in ionizable lipid synthesis

Solid-Phase Enzymatic Synthesis of a Lewis a Trisaccharide Using an Acceptor Reversibly Bound to Sepharose

Preparation and characterization of BSA-loaded liraglutide and platelet fragment nanoparticle delivery system for the treatment of diabetic atherosclerosis

Large-Scale Synthesis of LPA1-Receptor Antagonist ACT-1016-0707

Solid-phase synthesis of amine-bridged cyclic enkephalin analogues via on-resin cyclization utilizing the Fukuyama-Mitsunobu reaction